Inter Parfums, Inc. — Q1 2022 Form 10-Q
Reporting period: Three months ended March 31, 2022; unaudited consolidated results. Comparisons are with Q1 2021 unless otherwise noted. Amounts are in U.S. dollars; financial statement figures are in millions unless specified.
Business context and results
Inter Parfums manufactures, markets and distributes prestige fragrances through European and U.S. operations. Most products are sold under third-party licenses. European operations generated about 73% of Q1 sales. Sales benefited from strong fragrance demand, new products and newer brands; reported European sales were tempered by the stronger U.S. dollar.
| Metric | Q1 2022 | Q1 2021 | Change |
|---|---|---|---|
| Net sales | $250.7 | $198.5 | +26.3%; +30% at comparable exchange rates |
| Gross profit | $158.7 | $125.2 | +26.7% |
| Gross margin | 63.3% | 63.1% | +0.2 percentage points |
| Operating income | $61.2 | $48.0 | +27.6% |
| Operating margin | 24.4% | 24.2% | +0.2 percentage points |
| Net income | $46.3 | $36.6 | +26.4% |
| Net income attributable to Inter Parfums, Inc. | $35.3 | $27.7 | +27.6% |
| Diluted EPS | $1.10 | $0.87 | Up from prior year |
European operations sales increased 14% and U.S. operations sales increased 77%, as presented in MD&A. Brand gains included Montblanc, Coach and GUESS. The filing attributes improved European and U.S. gross margins to currency effects and better absorption of fixed costs, respectively. Advertising and promotion expense rose to $34.2 million from $21.8 million, or 13.6% of sales versus 11.0%; management expects full-year advertising and promotion to be about 21% of sales.
Cash flow, liquidity and debt
- Operating cash flow was a use of $23.9 million, versus $32.5 million provided in Q1 2021. Management said working-capital items used $73.2 million; accounts receivable and inventory increased amid record sales and supply-chain planning.
- Investing cash flow was a use of $11.8 million; financing cash flow was a use of $20.0 million. Cash and cash equivalents fell to $110.1 million from $159.6 million at year-end 2021.
- Cash, cash equivalents and short-term investments totaled approximately $265.2 million, including $20.7 million of marketable equity securities. Working capital was approximately $484 million and the working-capital ratio was 2.9:1. Management reported no liquidity issues and said available cash and credit facilities should meet foreseeable needs.
- Long-term debt, including its current portion, was approximately $139.5 million, down from $148.8 million at December 31, 2021. No short-term borrowings were outstanding under credit facilities. The Paris headquarters was financed in part by a 10-year €120 million loan; about €80 million was swapped, with a maximum rate of 2% per year.
- Quarterly dividends declared increased to $0.50 per share from $0.25. The board raised the annual dividend to $2.00 per share; the next $0.50 payment was scheduled for June 30, 2022.
Material changes, outlook and risks
- Management described Q1 as exceptionally strong and said growth catalysts outweighed headwinds, but provided no specific full-year sales or earnings guidance in the supplied filing text. Planned launches included brand extensions and new products; Donna Karan and DKNY licensing was to begin July 1, 2022, with new fragrances planned for 2023.
- Supply-chain constraints, component procurement and freight disruptions, and related cost increases were expected to persist until later in 2022. Management warned that prolonged disruption could materially harm sales and gross margin and said COVID-related effects could adversely affect results, financial position and cash flows through at least year-end 2022.
- International travel retail remained constrained, though management reported early signs of recovery. Russia and Ukraine represented about 4% of FY2021 consolidated sales; the conflict had no material Q1 financial-statement impact. Future effects of sanctions and counter-sanctions were uncertain. Management said most receivables there were insured or paid in advance.
- Foreign exchange affects reported sales and margins; the average dollar/euro rate was 1.12 versus 1.20 a year earlier. The company uses forward contracts to manage currency exposures and interest-rate swaps on part of its Paris loan.
- License continuity and renewals are important risks. License agreements carry minimum advertising, royalty and other commitments. The company also reported increased promotion and advertising investment as it supports launches and brand awareness.
- Interest and investment income/loss included approximately $3.4 million of losses on marketable equity securities. No impairment loss was recorded in Q1 2022, compared with $2.4 million in Q1 2021.
Important facts for investors to verify
- Reconcile U.S. sales comparatives: MD&A reports Q1 2021 U.S. sales of $38.8 million in one table, while the geographic financial-statement note reports $39.2 million.
- Track cash conversion, receivables and inventory growth, and whether supply constraints ease as management expected.
- Monitor advertising spending, new-brand launches, travel-retail recovery, and performance against any later-issued guidance.
- Assess exposure to licensed-brand renewals, Russia/Ukraine developments, currency movements and the variable-rate Paris headquarters loan.
- Review the full annual report’s commitments and risk disclosures; the 10-Q refers readers there for certain license commitments and risk factors.